To identify risk factors associated with positive HIV serostatus among African American women who smoke crack and/or inject drugs and who are not enrolled in drug treatment or another institutional setting.
Methods.
Baseline interviews were conducted from June 1998 to June 2000 with 379 heterosexually active women (ages 18 to 59) who had been recruited for potential enrollment into an HIV intervention trial.
Results.
Adjusted for age and drug using status, women who expressed more difficulty saying no to sex with male partners were more likely to be HIV-positive (adjusted odds ratio [aOR]=3.08, 95% confidence interval [CI] 2.02, 4.83). Similarly, those who indicated greater communication with casual sex partner(s) were less likely to test positive (aOR=0.29, 95% CI 0.10, 0.89). Lower HIV internal control and a history of cuts or burns on lips due to crack smoking were also associated with positive serostatus, and were important confounders in the final multivariate model. A higher level of internal control was associated with a decreased likelihood of positive serostatus, while a history of cuts or burns on the lips was associated with an increased likelihood of HIV antibodies, even after controlling for the amount of oral sex.
Conclusions.
A broad array of factors may promote or avert infection with HIV. The degree to which personal attributes and beliefs, and relationship characteristics contribute to the likelihood of infection must continue to be addressed. The importance of oral sex and presence of oral sores and their potential role in transmission was suggested.
References
1.
Centers for Disease Control and Prevention. Basic statistics. In: HIV/AIDS Surveillance Report. 2001 [cited 2002 Mar 5]. Available from: URL: http://www.cdc.gov/hiv/stats.htm#exposure
2.
MillerMNeaigusA. Networks, resources and risk among women who use drugs. Soc Sci Med2001; 52:967–78.
3.
Des JarlaisDCFriedmanSRPerlisTChapmanTFSotheranJLPaoneD. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol1999; 20:67–72.
4.
IckovicsJRYoshikawaH. Preventive interventions to reduce heterosexual HIV risk for women: current perspectives, future directions. AIDS1998; 12(Suppl A):S197–208.
5.
PadianNS. Prostitute women and AIDS: epidemiology. AIDS1988; 2:413–9.
6.
CoyleSL. Women's drug use and HIV risk: findings from NIDA's Cooperative Agreement for Community-Based Outreach/Intervention Research Program. Women Health1998; 27:1–18.
7.
NeaigusAMillerMFriedmanSRHagenDLSifaneckSJIldefonsoG. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction2001; 96:847–60.
8.
EhrhardtAAExnerTM. Prevention of sexual risk behavior for HIV infection with women. AIDS2000; 14(Suppl 2):S53–8.
9.
RothenbergRBScarlettMdel RioCReznikDO'DanielsC. Oral transmission of HIV. AIDS1998; 12:2095–105.
10.
FaruqueSEdlinBRMcCoyCBWordCOLarsenSASchmidDS. Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol1996; 13:87–92.
11.
StacyAWNewcombMDAmesSL. Implicit cognition and HIV risk behavior. J Behav Med2000; 23:475–99.
12.
MorrillACKastenLUratoMLarsonMJ. Abuse, addiction, and depression as pathways to sexual risk in women and men with a history of substance abuse. J Subst Abuse2001; 13:169–84.
13.
ComptonWMCottlerLBBen-AbdallahACunningham-WilliamsRSpitznagelEL. The effects of psychiatric comorbidity on response to an HIV prevention intervention. Drug Alcohol Depend2000; 58:247–57.
14.
St. LawrenceJSEldridgeGDBrasfieldTL. Behavioral and psychosocial consequences of HIV antibody counseling and testing with African American women. Womens Health1998; 4:135–53.
15.
WingoodGMDiClementeRJ. Cultural, gender, and psychosocial influences on HIV-related behavior of African-American female adolescents: implications for the development of tailored prevention programs. Ethn Dis1992; 2:381–8.
16.
SterkCETheallKPElifsonKW. Effectiveness of a risk reduction intervention among African American women who use crack cocaine. AIDS Educ Prev2003; 15:15–32.
17.
SterkCETheallKPElifsonKWKidderD. HIV risk reduction among African American female injection drug users: a randomized controlled trial. AIDS Behav2003; 7:73–86.
18.
WattersJKBiernackiP. Targeted sampling: options for the study of hidden populations. Soc Problems1989; 36:416–30.
19.
SterkCEDolanKHatchS. Epidemiological indicators and ethnographic realities of female cocaine use. Subst Use Misuse1999; 34:2057–72.
20.
TashimaNCrainSO'ReillyKSterk-ElifsonC. The community identification process: a discovery model. Qualitative Health Res1996; 6:23–48.
21.
GalloDGeorgeJRFitchenJHGoldsteinASHindahlMS. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group. JAMA1997; 277:254–8.
22.
ElifsonKWSterkCE. Case study: the health intervention project. In: BlumenthalAMDiClementeRJ, editors. Community-based research: issues and methods. New York: Springer; 2003.
23.
RotterJB. Generalized expectancies for internal versus external control of reinforcement. Psychol Monograph1966; 80:1–28.
24.
LefcourtHM. New directions in research with the locus of control construct. Psychol Studies1984; 29:107–11, 22.
25.
BraffordLJBeckKH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health1991; 39:219–25.
26.
BrownEJ. Female injecting drug users: human immunodeficiency virus risk behavior and intervention needs. J Prof Nurs1998; 14:361–9.
27.
KleinbaumDG. Modeling strategy guidelines. In: DietzAMGailMKrickebergKSingerB, editors. Logistic regression: a self-learning text. New York: Springer-Verlag; 1994 p. 161–89.
28.
LaneHCHolmbergSDJaffeHW. HIV seroconversion and oral intercourse. Am J Public Health1991; 81:658.
29.
RozenbaumWGharakhanianSCardonBDuvalECoulaudJP. HIV transmission by oral sex. Lancet1988; 1:1395.
30.
HalkitisPNParsonsJT. Oral sex and HIV risk reduction: perceived risk, behaviors, and strategies among young HIV-negative gay men. J Psychol Hum Sex2000; 11:1–24.
31.
WeinhardtLSCareyKBCareyMP. HIV risk sensitization following a detailed sexual behavior interview: a preliminary investigation. J Behav Med2000; 23:393–8.
32.
VernazzaPLEronJJCohenMSvan der HorstCMTroianiLFiscusSA. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS1994; 8:1325–9.
33.
IlariaGJacobsJLPolskyBKollBBaronPMacLowC. Detection of HIV-1 DNA sequences in pre-ejaculatory fluid. Lancet1992; 340:1469.
34.
LevyJA. Human immunodeficiency viruses and the pathogenesis of AIDS. JAMA1989; 261:2997–3006.
35.
WallaceJIPorterJWeinerASteinbergA. Oral sex, crack smoking, and HIV infection among female sex workers who do not inject drugs. Am J Public Health1997; 87:470.
36.
PorterJBonillaL. Crack users' cracked lips: an additional HIV risk factor. Am J Public Health1993; 83:1490–1.
37.
InciardiJAChitwoodDDMcCoyCB. Special risks for the acquisition and transmission of HIV infection during sex in crack houses. J Acquir Immune Defic Syndr1992; 5:951–2.
38.
SterkCE. Fast lives: women who use crack cocaine. Philadelphia: Temple University Press; 1999.
39.
Mitchell-LewisDAPhelanJAKellyRBBradleyJJLamsterIB. Identifying oral lesions associated with crack cocaine use. J Am Dent Assoc1994; 125:1104–8, 1110.
40.
RosenbaumM. Women on heroin. New Brunswick (NJ): Rutgers University Press; 1981.
41.
MaguraSGoldsmithDCasrielCGoldsteinPJLiptonDS. The validity of methadone clients' self-reported drug use. Int J Addict1987; 22:727–49.
42.
McElrathKChitwoodDDGriffinDKComerfordM. The consistency of self-reported HIV risk behavior among injection drug users. Am J Public Health1994; 84:1965–70.
43.
NeedleRFisherDGWeatherbyNChitwoodDBrownBCesariH. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addictive Behav1995; 9:242–50.
